{
  "retracted": false,
  "timestamp": 1501545600000,
  "updates": [
    {
      "timestamp": 1550484429262,
      "identifier": {
        "doi": "10.1212/cpj.0000000000000380"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1212/cpj.0000000000000342"
  },
  "journal": "Neurology: Clinical Practice",
  "publisher": "Ovid Technologies (Wolters Kluwer Health)",
  "title": "Pimavanserin: A novel therapeutic option for Parkinson disease psychosis"
}
